1-3 of 3
Michel Dreano, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

Michel Jourdan, PhD, Jerome Moreaux, PhD, Dirk Hose, MD, Jean-Francois Rossi, MD, PhD, Karène Mahtouk, PhD, Mathieu Aboulaze, Nicolas Robert, Marion Baudard, MD, PhD, Thierry Reme, MD, PhD, Angela Romanelli, Hartmut Goldschmidt, MD, Michel Dreano, PhD, Bernard Klein, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3472.
https://doi.org/10.1182/blood.V108.11.3472.3472
Published: 2006
Journal Articles

Pharmacological Blockade of NF-kB Targets Both Imatinib-Sensitive or -Resistant Chronic Myeloid Leukemia Cells for Cell Death.

Véronique Imbert, PhD, Nadia Lounnas, Catherine Frelin, PhD, Nadège Gonthier, Emmanuel Griessinger, Nicolas Sirvent, MD, Michael Hummelberger, MD, Jil-Patrice Cassuto, MD, François-Xavier Mahon, MD, Jean-François Michiels, MD, Philippe Rousselot, MD, Michel Dreano, PhD, Jean-François Peyron, PhD
Journal: Blood
Blood (2006) 108 (11): 4793.
https://doi.org/10.1182/blood.V108.11.4793.4793
Published: 2006
Journal Articles

Pharmacological Blockade of NF-kB with AS602868, a Potent Small Molecule Inhibitor of IKK2 Leads to Apoptosis of Sensitive and Resistant Chronic Myeloid Leukemia Cells.

Veronique Imbert, PhD, Nadege Gonthier, PhD, Catherine Frelin, PhD, Nicolas Sirvent, MD, Michael Hummelsberger, MD, Anne Sirvent von Bueltzingsloewen, MD, Jill-Patrice Cassuto, MD, Francois-Xavier Mahon, MD, Philippe Rousselot, MD, Michel Dreano, PhD, Jean-Francois Peyron, PhD
Journal: Blood
Blood (2005) 106 (11): 2882.
https://doi.org/10.1182/blood.V106.11.2882.2882
Published: 2005